A newlywed has become the first NHS patient in England with an aggressive form of leukaemia to have a pioneering treatment ...

AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...

RNA Drugs: presented yesterday in Naples, at the research area of Naples of the CNR, in via Pietro Castellino, the results of ...

Cancer survival rates have reached a record high, according to a new report from the American Cancer Society (ACS). The ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

The US president vowed to ‘end childhood cancer’. But his administration is dismantling the search for a cure and sending families scrambling for treatment ...

The American Cancer Society’s 2026 Cancer Statistics report shows the five-year survival rate for all cancers has reached a ...

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

Forty percent of cancers are preventable, and diet is one of the biggest levers at one's control, according to a Sylvester expert on lifestyle ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 15, 2026 /Cell Source, Inc. (OTC Pink Limited:CLCS) ("Cell Source" or the "Company"), a leading innovator in immune tolerance management, announced ...

Surrounded by family and friends, Lane rang the bell, which symbolizes the end of cancer treatments, at Atrium Health Levine ...